NCT00813956 · Interventional trial
A Phase 2 Study of Standard Chemotherapy Plus BSI-201 (a PARP Inhibitor) in the Neoadjuvant Treatment of Triple Negative Breast Cancer
Overall registry status Completed
Phase 2
Conditions Triple Negative Breast Cancer
Delaware Valley sites
- PrECOG · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory